FINANCIAL NEWS

Better To Ignore Nufarm’s Guidance Downgrade
Nufarm’s guidance miss was largely due to two unplanned outages, now resolved, while record growth in Seeds more than offsets headwinds for Crop Protection
1:04 PM
Australian Broker Call *Extra* Edition – Sep 24, 2026
Extra Edition of the Broker Call Report
12:40 PM
The Short Report – 24 Sep 2026
FNArena’s weekly update on short positions in the Australian share market
10:30 AM
Telix Aims For A Strategic Isotope Supply Chain
Telix Pharmaceutical’s proposed acquisition of a global isotope manufacturing supplier brings forth a strategically significant opportunity, although not without risks
10:00 AM
The Overnight Report: Yields Rise, Markets Fall
A global perspective on what happened overnight
8:30 AM
Citi rates BAP as Neutral

Looking into Bapcor's remuneration structure, Citi views the FY27 performance rights as easier to vest than the FY26, which should support better management retention.
The analyst believes the complete remuneration structure has been implemented to encourage and maximise management stability and incentivise a turnaround.
Neutral rating is retained with the broker highlighting ongoing caution around the consumer and macro-economic backdrop, against a potential pathway of initiatives to improve financial performance.
Target 69c.
UBS rates KMD as Buy

FY26 underlying earnings (EBITDA) for KMD Brands (July year-end) more than doubled to NZ$42m, supported by 11% Kathmandu sales growth, improved gross margins and NZ$8m of tariff refunds, UBS explains.
Higher operating costs prompt UBS to cut its FY27–FY29 earnings forecasts by -20%–29%.
The broker forecasts FY27 earnings of NZ$54m, near the top of the NZ$52m–NZ$55m guidance range but expects limited operating leverage.
It is felt the balance sheet has been de-risked following the equity raising. The company has received several preliminary takeover approaches.
UBS lowers its target to NZ$2.55 from NZ$3.50 and retains its Buy rating, mainly on valuation grounds.
Bell Potter rates NUF as Buy

Bell Potter raises its target for Nufarm to $3.90 from $3.75 and retains its Buy rating following yesterday's FY26 trading update.
Implying 25% year-on-year growth, underlying earnings (EBITDA) guidance of $370m–$380m is consistent with the broker's $375m forecast.
Hybrid Seeds and Omega-3 are performing strongly, the analysts note, with Seeds tracking towards a record result. Crop Protection remains broadly stable despite North American weakness and unplanned plant outages, commentary adds.
Bell Potter raises its FY27 and FY28 earnings forecasts by 3% and 2%, respectively, expecting outage costs not to recur.
Net debt-to-earnings is expected to improve to around 2.0x from 2.7x.
Click here to see full report 
ANALYSIS & DATA
FNARENA'S MARKET CONSENSUS FORECASTS
To display the stock analysis for a company please enter the company code:
ANZ | ANZ GROUP HOLDINGS LIMITED
Abbreviated format - see the full version here
| LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
|---|---|---|---|
$37.83 23 Sep |
OPEN $38.02 |
HIGH $38.11 | 2,875,269 LOW $37.55 |
| TARGET | |||
| $35.922-5.0% downside | |||
| Franking for last dividend paid out: 75% |
| Title | FY24 Actual | FY25 Actual | FY26 Forecast | FY27 Forecast |
|---|---|---|---|---|
| EPS (cps) | xxx | 198.2 | 247.3 | xxx |
| DPS (cps) | xxx | 166.0 | 166.7 | xxx |
| EPS Growth | xxx | - 9.1% | 24.8% | xxx |
| DPS Growth | xxx | 0.0% | 0.4% | xxx |
| PE Ratio | xxx | N/A | 15.1 | xxx |
| Dividend Yield | xxx | N/A | 4.5% | xxx |
| Div Pay Ratio(%) | xxx | 83.8% | 67.4% | xxx |
FOLLOW US ON SOCIAL MEDIA







DAILY FINANCIAL NEWS
Better To Ignore Nufarm’s Guidance Downgrade
Nufarm’s guidance miss was largely due to two unplanned outages, now resolved, while record growth in Seeds more than offsets headwinds for Crop Protection
1:04 PM - Small Caps
Telix Pharmaceutical’s proposed acquisition of a global isotope manufacturing supplier brings forth a strategically significant opportunity, although not without risks
10:00 AM - Australia
Australian consumers are proving surprisingly resilient, but analysts warn higher rates, falling house prices and rising costs could increasingly test discretionary spending through FY27
Sep 23 2026 - Australia
A glance through the latest expert views and predictions about commodities: Ongoing Middle East conflict to push up oil and LNG prices; Russian sulphuric acid ban impacts copper; lower food supply and weather risks inform agriculture views
Sep 23 2026 - Commodities
After materially and persistently underperforming Hub24, Netwealth is turning to AI-powered adviser productivity through its Paradino acquisition
Sep 22 2026 - Australia
After almost retracing its year-to-date rally, Fairmont Equities’ Michael Gable notes Lynas shares have bounced strongly from below $14 on high volume
Sep 22 2026 - Technicals
PR NEWSWIRE
Humanforce named a Major Contender in the Everest Group Workforce Management Products PEAK Matrix® Assessment 2026 and the Everest Group Human Capital Managemen
10:10 AM - PR NewsWire
QuintessenceLabs Introduces TSF® Sentry Cryptographic Assessment and PQC Readiness Assessment at Quantum World Congress
Sep 23 2026 - PR NewsWire
Carbon Trade eXchange Launches CTX Corporate One for Institutional-Scale, High-Quality Carbon Credits
Sep 23 2026 - PR NewsWire
Mayo Clinic Laboratories Invests in Pathology Asia Holdings and LifeStrands Genomics to Advance Diagnostics and Precision Medicine
Sep 23 2026 - PR NewsWire
FXT Unveils FXT AI: A Multi-Agent Trading Co-Pilot for Market Insight, Risk Awareness and Trader Development.
Sep 23 2026 - PR NewsWire
Made for Australians: Why Samsung Home Appliances Are Designed for the Way Australians Live
Sep 23 2026 - PR NewsWire

RUDI'S VIEWS
Rudi’s View: Australia’s Most Unloved Buy-Rated Stocks
A deeper dive in the highest rated, though unloved stocks on the ASX
Sep 23 2026
DAILY MARKET REPORTS
Australian Broker Call *Extra* Edition – Sep 24, 2026
Extra Edition of the Broker Call Report
12:40 PM
The Overnight Report: Yields Rise, Markets Fall
A global perspective on what happened overnight
8:30 AM
ASX Winners And Losers Of Today – 23-09-26
The table inside ranks the 20 biggest percentage winners and losers among stocks in the ASX300 at the end of each trading day
Sep 23 2026
Australian Broker Call *Extra* Edition – Sep 23, 2026
Extra Edition of the Broker Call Report
Sep 23 2026
The Overnight Report: Nasdaq’s New Record High
A global perspective on what happened overnight
Sep 23 2026
Today’s Financial Calendar – 23-09-2026
Significant Scheduled Events For 23 September, 2026
Sep 23 2026
WEEKLY REPORTS
The Short Report – 24 Sep 2026
FNArena’s weekly update on short positions in the Australian share market
10:30 AM
Weekly Update On LICs & LITs – 23-Sep-2026
Weekly update of Listed Investment Companies (LICs) & Listed Investment Trusts (LITs) on the ASX
Sep 23 2026
Australian Listed Real Estate Tables – 22-09-2026
FNArena provides a weekly update of Australian listed real estate trusts (REIT) and property developers, current pricing yield and valuation data
Sep 22 2026
Uranium Week: DevEx, Silex & Westinghouse IPO
A becalmed spot market failed to capture the robust news flow across the U308 sector, including media reports on the upcoming Westinghouse IPO in October
Sep 22 2026
Weekly Ratings, Targets, Forecast Changes – 18-09-26
Weekly update on stockbroker recommendation, target price, and earnings forecast changes
Sep 21 2026
Next Week At A Glance – 21-25 Sep 2026
A brief look at important company events and economic data releases next week
Sep 18 2026
Weekly Top Ten News Stories – 18 September 2026
Our top ten news stories from 10 September 2026 to 17 September 2026
Sep 18 2026
In Case You Missed It – BC Extra Upgrades & Downgrades – 18-09-26
A summary of the highlights from Broker Call Extra updates throughout the week past
Sep 18 2026
In Brief: SCX.AI, RocketDNA & Silex Systems
This week’s In Brief highlights three good news stories from the week past
Sep 18 2026
THE MARKETS
Click item/line to change chart
FNARENA WINDOWS
Window on AGRICULTURE
Better To Ignore Nufarm’s Guidance Downgrade
Nufarm’s guidance miss was largely due to two unplanned outages, now resolved, while record growth in Seeds more than offsets headwinds for Crop Protection
1:04 PM
Window on PHARMACEUTICALS & BIOTECH/LIFESCIENCES
Telix Aims For A Strategic Isotope Supply Chain
Telix Pharmaceutical’s proposed acquisition of a global isotope manufacturing supplier brings forth a strategically significant opportunity, although not without risks
10:00 AM
Window on CONSUMER PRODUCTS & SERVICES
Australian Consumers Showing Pain & Resilience
Australian consumers are proving surprisingly resilient, but analysts warn higher rates, falling house prices and rising costs could increasingly test discretionary spending through FY27
Sep 23 2026
GEN AI
Netwealth Adds AI To Close Gap With Hub24
After materially and persistently underperforming Hub24, Netwealth is turning to AI-powered adviser productivity through its Paradino acquisition
Sep 22 2026

-0.320










